XML 18 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Statements of Cash Flows (unaudited) - USD ($)
8 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2018
Cash flows from operating activities:    
Net income (loss) attributable to ordinary shares $ (218,915) $ 4,692,837
Changes in operating assets and liabilities:    
Prepaid expenses (165,429) 61,977
Accrued offering costs, formation costs and other expenses 323,987 11,099
Interest on Investments held in Trust Account 0 (5,285,412)
Withdrawal of interest from Trust Account to pay operating expenses 0 750,000
Net cash provided by (used in) operating activities (60,357) 230,501
Cash flows from investing activities:    
Proceeds deposited into Trust Account (450,000,000) 0
Net cash used in investing activities (450,000,000) 0
Cash flows from financing activities:    
Proceeds from sale of Units in initial public offering 450,000,000 0
Proceeds from sale of Private Placement Warrants to Sponsor 11,000,000 0
Proceeds of notes payable from Sponsor 300,000 0
Payments of underwriting discounts (9,000,000) 0
Payment of accrued offering costs (328,100) (89,747)
Repayment of notes payable from Sponsor (300,000) 0
Net cash provided by (used in) financing activities 451,696,900 (89,747)
Net change in cash 1,636,543 140,754
Cash at beginning of period 0 372,073
Cash at end of period 1,636,543 512,827
Supplemental disclosure of non-cash financing activities:    
Deferred underwriting compensation 15,750,000 0
Accrued offering costs 971,123 0
Class F ordinary shares    
Cash flows from operating activities:    
Net income (loss) attributable to ordinary shares 0 0
Cash flows from financing activities:    
Proceeds from sale of Class F ordinary shares to Sponsor $ 25,000 $ 0